IP Library Granted Patent US 8,554,326
Granted Patent B2
US 8,554,326 · App. 13/830,788 · Granted Oct 8, 2013

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,554,326
App. No.
13/830,788
Granted
Oct 8, 2013
Kind
B2
Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (35)

1. A method for configuring a spinal modulation system to deliver a therapy signal to a patient's spinal cord region, for treating a patient's pain, wherein the spinal modulation system includes

an implantable signal delivery device having a plurality of electrical contacts implantable proximate to a vertebral level in a range of from about T9 to about T12, and

a signal generator electrically coupleable to the implantable signal delivery device to generate a therapy signal and deliver the therapy signal to the patient's spinal cord region via the implantable signal delivery device,

the method comprising:

programming the signal generator to generate and deliver the therapy signal to two electrical contacts that are only contralateral to the pain, wherein at least a portion of the therapy signal has a frequency in a frequency range of from about 1.5 kHz to about 50 kHz.

2. The method of claim 1 , wherein the therapy signal reduces or inhibits contralateral pain without generating paresthesia.

3. The method of claim 1 , wherein the frequency range is from about 3 kHz to about 20 kHz.

4. The method of claim 1 , wherein the frequency range is from about 5 kHz to about 15 kHz.

5. The method of claim 1 , wherein the frequency range is from about 3 kHz to about 10 kHz.

6. The method of claim 1 , wherein at least a portion of the therapy signal is at a frequency of about 10 kHz.

7. The method of claim 1 , wherein the therapy signal reduces or inhibits at least one of low-back pain and leg pain.

8. The method of claim 1 , wherein the therapy signal reduces or inhibits both low-back pain and leg pain.

9. The method of claim 1 wherein the pain is a first pain and wherein the patient has a second pain, ipsilateral to the two electrical contacts.

10. A method for configuring a spinal modulation system to deliver a therapy signal to a patient's spinal cord, for treating a patient's pain, wherein the spinal modulation system includes

an implantable signal delivery device having a plurality of electrical contacts, and

a signal generator electrically coupleable to the implantable signal delivery device to generate a non-paresthesia-generating therapy signal and deliver the non-paresthesia-generating therapy signal to the patient's spinal cord region via the implantable signal delivery device,

the method comprising:

programming the signal generator to generate and deliver the non-paresthesia-generating therapy signal to only at least one electrical contact positioned contralateral to the pain, wherein at least a portion of the non-paresthesia-generating therapy signal has a frequency in a frequency range of from about 1.5 kHz to about 50 kHz.

11. The method of claim 10 , wherein the frequency range is from about 3 kHz to about 20 kHz.

12. The method of claim 10 , wherein the frequency range is from about 5 kHz to about 15 kHz.

13. The method of claim 10 , wherein the frequency range is from about 3 kHz to about 10 kHz.

14. The method of claim 10 , wherein at least a portion of the therapy signal is at a frequency of about 10 kHz.

15. The method of claim 10 , wherein the therapy signal reduces or inhibits at least one of low-back pain and leg pain.

16. The method of claim 10 , wherein the therapy signal reduces or inhibits both low-back pain and leg pain.

17. A method for configuring a spinal modulation system to deliver a therapy signal to a patient's spinal cord, for treating a patient's pain, wherein the spinal modulation system includes

a single percutaneous lead having a plurality of electrical contacts, and

an implantable pulse generator (IPG) coupleable to the percutaneous lead and configured to generate a therapy signal and deliver the therapy signal to the patient's spinal cord region via the percutaneous lead,

the method comprising:

implanting the percutaneous lead such that at least one of the electrical contacts is positioned contralateral to the patient's pain, relative to a midline of the patient's spinal cord; and

programming the IPG to generate and deliver the therapy signal to only the at least one electrical contact positioned contralateral to the patient's pain, wherein at least a portion of the signal has a frequency in a frequency range of from about 1.5 kHz to about 50 kHz.

18. The method of claim 17 , wherein the therapy signal reduces or inhibits contralateral pain without generating paresthesia.

19. The method of claim 17 , wherein the frequency range is from about 3 kHz to about 20 kHz.

20. The method of claim 17 , wherein the frequency range is from about 5 kHz to about 15 kHz.

21. The method of claim 17 , wherein the frequency range is from about 3 kHz to about 10 kHz.

22. The method of claim 17 , wherein at least a portion of the therapy signal is at a frequency of about 10 kHz.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 030647 FRAME: 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 21, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040658/0479 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2013
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 030647/0001 →